J&J EXEC SAYS RESTRUCTURING PROGRAM FOR SURGERY BUSINESS IS EXPECTED TO BE COMPLETED IN 2027 WITH COST ESTIMATED AT ABOUT $900 MLN

Reuters · 2d ago

Please log in to view news